Quantity: 50 MG
Available on backorder
Product name: Myr-HBVpreS/2-78
Modifications: N-terminus myristoylation, C-terminus amide,
Purity: 95% by HPLC
Counter ion: Trifluoacetate
Format: Lyophilized powder
Description: Chronic HBV infection is the leading cause of liver cirrhosis and hepatocellular carcinoma (HCC). Synthetic peptides derived from the N-terminus of the large HBV envelope protein (L-protein) have been shown to efficiently block HBV entry. Myr-HBVpreS/2-78, the parent compound of these drugs, inhibits human HBV infection in vitro and in vivo.
Usage: For Scientific Research Use Only, Not for Human Use.